Research Article
Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019– (COVID-19–) Associated Acute Kidney Injury
Figure 1
Cell-free DNA (cfDNA) levels in COVID-19 patients based on severity of acute kidney injury (AKI) (a) and need for renal replacement therapy (RRT) (b); receiver operating characteristic curve (ROC) of cfDNA for severe AKI (c, left) ( (95% CI: 0.67-0.97)); and ROC of cfDNA for the need for RRT (c, right) ( (95% CI: 0.54-0.98)).
(a) |
(b) |
(c) |
(d) |